What is Allure Labs?
Operating as an FDA-registered custom contract manufacturer, Allure Labs functions as a critical infrastructure provider for the beauty and personal care sectors. With a 65,000 square foot, state-of-the-art facility, the company integrates advanced manufacturing methodologies with rigorous quality control protocols. Their business model centers on a collaborative approach, pairing clients with dedicated project coordinators and expert chemists to navigate the complexities of custom formulation. This high-touch service model ensures that brands can scale production without compromising on ingredient integrity or regulatory compliance, effectively bridging the gap between laboratory innovation and commercial-scale distribution.
How much funding has Allure Labs raised?
Allure Labs has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Allure Labs
PPP
Public-Private Partnership
What's next for Allure Labs?
With the recent capital injection, Allure Labs is poised to transition into a more aggressive growth phase, likely focusing on the expansion of its technical infrastructure and the optimization of its supply chain logistics. As the demand for high-quality, domestic manufacturing continues to rise, the company is expected to utilize these funds to enhance its machinery fleet and broaden its service offerings. By deepening its commitment to advanced manufacturing, Allure Labs aims to capture a larger share of the private label market, providing the necessary stability and technical expertise for emerging and established brands to thrive in a competitive retail landscape.
See full Allure Labs company page
